Webinar: Japan’s Regulatory Requirements for Cell and Gene Therapy
On the latest C-Cast mini-webinar by CMIC, Dr. Kazuhiro Fukuta, Senior Consultant and the Head of Regenerative Medicine Group in [...]
Webinar on Successful Gene Therapy Development
An on-demand webinar by Certara details how pharmaceutical companies can streamline their drug development process. Although gene therapy treatments are [...]
Addressing the Affordability Crisis of Cell & Gene Therapies
In a recent Reuters Events poll, 43% of pharma said that reimbursement policy and legislation (e.g Best Price) is the [...]
Innovative Payments, Management are Needed for Cell and Gene Therapies
Cell and gene therapies are a transformative approach that provides new therapeutic options for patients with cancer, immune disorders, hemophilia, [...]
Reimbursing Innovative and Potentially Curative Gene and Cell Therapies
In this feature, following his participation in a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific [...]
Methodological Considerations in Economic Evaluations of Gene Therapies
Researchers recently performed a study aiming to identify methodological considerations in the research literature addressing economic evaluations (EEs) of gene [...]
BioMarin CFO Exits Before Release of Costly Drug
BioMarin Pharmaceutical is searching for a new chief financial officer following Dan Spiegelman's exit last week, Forbes reports. The executive's [...]
